IBIO - iBio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.8 0.03 (3.85%) --- --- 0.0 (0.12%) 0.01 (1.1%) 0.04 (5.48%) -0.02 (-2.18%) -0.02 (-2.18%)

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.75
Diluted EPS:
-1.75
Basic P/E:
-0.4749
Diluted P/E:
-0.4749
RSI(14) 1m:
10.96
VWAP:
0.83
RVol:
1.4689

Events

Period Kind Movement Occurred At
1m Price increase 1m 0.85 +0.01 (+1.16%) Oct 15 15:59
1m Price decrease 1m 0.81 -0.01 (-1.1%) Oct 15 13:23
1m Price decrease 1m 0.81 -0.01 (-1.23%) Oct 15 10:28
1m Price increase 1m 0.84 +0.01 (+1.19%) Oct 15 09:59

Related News